Understanding Alkaptonuria: A Research Study
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study examines alkaptonuria, a rare inherited condition where the body cannot break down certain amino acids, leading to dark urine and joint problems. Researchers want to learn more about how this disease develops and progresses to improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with alkaptonuria (a rare inherited metabolic disorder)
- You are at least 2 years old
- You are healthy enough to travel to the National Institutes of Health (NIH) in Maryland
- You do not have severe heart or life-threatening complications from alkaptonuria
- You are willing to undergo diagnostic testing to confirm your alkaptonuria diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether new protein substitute tablets are acceptable for people with certain rare metabolic disorders. Participants will replace their usual protein substitute with the study tablets for 7 days to see if they can tolerate them.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
This research study follows patients with methylmalonic acidemia (a rare metabolic disorder affecting how the body breaks down certain proteins) or cobalamin (vitamin B12) disorders to better understand how these conditions develop and progress over time. Researchers will collect medical information, blood samples, and eye exams to help improve future treatments.
This trial studies blood and other measurable signs (biomarkers) that may reflect brain injury after certain inherited metabolic conditions. Results may help doctors better detect and understand brain effects from these illnesses, especially episodes that affect the brain.
This study follows people with rare genetic conditions (GM1, GM2, sialidosis, or galactosialidosis) that affect how the body breaks down certain substances in cells. Researchers track how these diseases progress to better understand them and potentially help future patients.
This study follows people with propionic acidemia to better understand how the body, diet, gut bacteria, and blood chemistry change over time. It may help researchers learn more about the condition and how pregnancy, transplant, and daily life affect health.
Hear when a new Alkaptonuria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.